Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Valeo Pharma In-Play, New HesperCo™ Immune System Support Scientifically Demonstrated

Shares of Valeo Pharma Inc. (CSE: VPH) (Frankfurt: VP2) poised for substantial upside revaluation to reflect the major ‘company –maker’ potential in HesperCo™ as the market figures out it is set to be the subject of Covid-19 clinical trial. Valeo will benefit...
Fredrick William | September 2, 2020 |

Enzo Biochem Shares Rise 60% as the Firm Commences COVID-19 Lab Testing

Shares of Enzo Biochem traded higher after the company advised that they will launch coronavirus testing services starting next week. Enzo Biochem Inc. (ENZ:NYSE) today announced that "its wholly owned subsidiary, Enzo Clinical Labs Inc., will begin accep...
Streetwise Reports | March 9, 2020 |

US between Scylla and Charybdis

I’m just going to come right out and say it: The United States is not equipped to deal with a pandemic. The nation of 327 million, despite having the number one economy in the world, and by far the most powerful military, is shockingly ill-prepared, not only ...
Richard (Rick) Mills | March 31, 2020 |

Biotech Identifies Antibody with 100% SARS-CoV-2 Inhibition

The goal of Sorrento Therapeutics to develop a Covid-19 antibody cocktail, including its progress, next steps and market opportunity, is reviewed in a Dawson James report. In a May 26 research note, Dawson James analyst Jason Kolbert reported that Sorrento Therape...
Streetwise Reports | May 28, 2020 |

Buzz on the Bullboards – Battery Day; A Brave New World for Mining?

Investors were a-buzz over Tesla’s ( NASDAQ: TSLA ) “Battery Day” events this week and the tech company’s latest offerings. While its so-called new type of battery cell and vehicle models left audiences feeling rathe...
Stockhouse Editorial | September 23, 2020 |

Vangold Mining, a Silver-Gold Junior Taking Mexico by Storm

Timing is everything. Precious metals are up when almost everything else is down. Gold has soared 38% from last year's low. This is a big move, but few investors seem to appreciate its significance. Earlier this week, Bank of America announced a gold price target of US$3,...
Streetwise Reports | April 24, 2020 |

Will the US Solar energy industry survive the COVID-19 crisis?

There are hardly any sectors not affected by Covid-19, including the US solar industry. The US solar industry is affected by compounding issues, delays in supply chains, strengthening the tax equity market, financial concerns of homeowners, shelter-in-place orders, and challen...
Ved Prakash | May 22, 2020 |

Junior Miner Awaits Assay on Core Sample from Alaskan Prospect

Maurice Jackson: Today we will find out the latest developments from Millrock Resources Inc. (MRO:TSX.V; MLRKF:OTCQB) regarding drilling and assay results on the 64 North Gold Project, located in the prolific Tintina gold province in Alaska. Joining us for a conversati...
Streetwise Reports | April 6, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

Copper bulls ride on increased orders, mine disruptions

Hit hard by the pandemic when it first struck China in February, then again in March when it spread to the Middle East, Europe and North America, over the past month copper prices have ticked up, as economies gradually reopen and growth prospects improve. True to its “Dr. ...
Richard (Rick) Mills | June 12, 2020 |
1 2 3 4 5 6 7 8 9 10 ...